To determine the effect of a lipid-lowering agent and/or a low-dose antithrombotic agent on the progression of early-stage carotid atherosclerosis, noninvasive B-mode ultrasound was used to measure intimal-medial thickness in asymptomatic individuals with moderately elevated lipids as part of the ongoing multicenter Asymptomatic Carotid Artery Plaque Study.
7 that use as their end point an ultrasonicalry determined measure of atherosclerosis derived from measurements of intimalmedial thickness (IMT) . 89 Multicenter studies in particular require consistently high-quality standardized B-mode images of arterial walls, given the potential for variation from clinic to clinic. Furthermore, standard clinical protocols that assess arterial disease (using angiography and Doppler ultrasound) focus on measurements of arterial From the Departments of Neurology (W.A.R., R.W.B.), Neurobiology and Anatomy (M.G.B.), and Public Health Sciences (W.A.R., C.D.F.), Bowman Gray School of Medicine, Winston-lumen and blood flow abnormalities in contrast to those of the artery wall. Although a number of factors other than sonographer performance contribute to measurement reliability, including ultrasound instrumentation and reader performance, the critical dependence of B-mode image quality on interrogation angle and fine adjustment of instrument controls makes the role of the sonographer central to the measurement process.
To determine the effect of sonographer performance on the end point measurement of atherosclerosis in the ongoing Asymptomatic Carotid Artery Plaque Study (ACAPS), we assessed both within-sonographer (W) and between-sonographer (B) reproducibility by comparing pairs of exams performed at 1-month intervals. This article summarizes these results and discusses their implications for monitoring small rates of change in carotid IMT (which very likely reflect progression/ regression of carotid artery atherosclerosis) in multicenter clinical trials. Reproducibility results associated with the B-mode image reading process are also presented.
Subjects and Methods

The Asymptomatic Carotid Artery Plaque Study
The Asymptomatic Carotid Artery Plaque Study is a double-blind, placebo-controlled, multicenter clinical trial of high-risk individuals with asymptomatic carotid stenosis. 10 (Participating institutions and principal staff are listed in the Appendix. ) The primary objective of ACAPS is to determine, using a factorial design, whether lovastatin (20-40 mg/day) and/or warfarin (1 mg/day), taken with aspirin (81 mg/day) over an average treatment period of 30-36 months, retards the progression of early atherosclerotic lesions in the carotid arteries, as measured by semiannual B-mode ultrasound. Those eligible for participation include men and women 40-79 years of age (inclusive) who have serum low density lipoprotein cholesterol levels of 130-189 mg/dl (inclusive) but no history of myocardial infarction, severe angina, stroke, or transient ischemic attack.
Subjects also must show evidence of early atherosclerotic development in the carotid arteries, as defined by at least one measurement of IMT >1.5 mm in the common or internal carotid artery or >1.6 mm in the bifurcation but <3.5 mm at any carotid site. The 0.1-mm difference between the lower cutoff points for the bifurcation (1.6 mm) and the common/internal carotid arteries (1.5 mm) takes into account the 0.1-mm greater wall thickness in the bifurcation compared with the other two segments in normal, young adults. The qualifying lesion must also demonstrate irregular, nonuniform wall thickening, a typical characteristic of focal atherosclerotic lesions.
Ultrasonic End Point Measurements and Scanning Protocol
The primary outcome measure of extent and severity of atherosclerosis in the carotid arteries is the mean of 12 measurements of the maximum IMT obtained independently from the near and far walls of three arterial segments on each side: the near wall and far wall of the proximal 8 mm of the internal carotid artery, the near wall and far wall of the carotid bifurcation, beginning at the tip of the flow divider and extending 8 mm proximal, and the near wall and far wall of the arterial segment extending 8-16 mm proximal to the tip of the flow divider into the common carotid artery. The 8-mm length of each segment is defined relative to the tip of the flow divider, which is normally the most clearly defined anatomic reference in the carotid system. Figure 1 is a simplified diagram that defines the location of these segments. Maximum IMT measurements are made on these images to determine the primary end point. The secondary end point is the single maximum IMT of the 12 measurements obtained. Subjects eligible for ACAPS must have a minimum of four high-quality IMT measurements from each carotid system.
The high-resolution B-mode ultrasound system selected for use was the Biosound Phase 2. Additional instrumentation and equipment required to obtain the ultrasonic B-mode image data include a high-resolution S-VHS videocassette recorder, a study flow panel and electrocardiogram marker, and a personal computer.
In preparation for the scanning protocol, sonographers monitor instrument performance by obtaining standardized images of a tissue-equivalent phantom and storing this information to provide a database that documents stability of the measurement process over time. For the scanning protocol, sonographers use a careful longitudinal interrogation of the complete cir- 
Sonographer and Reader Certification
The required use of two ACAPS sonographers at each clinical center permits measurement of both within-sonographer and between-sonographer measurement reproducibility. All sonographers completed a uniform 3-month training program conducted by the ultrasound center and subsequently earned certification on completion of the program. 10 To maintain the high quality of the ultrasound component of ACAPS, ultrasound center personnel perform quarterly site visits to monitor performance. In addition, ACAPS sonographers must obtain annual recertification. Within-and between-sonographer reproducibility data and the frequency of segment visualization from baseline and 6-month follow-up visits serve as primary criteria in the recertification process.
The ultrasound readers also received certification on satisfactory completion of a standard 3-month training program. Like the sonographers, readers must obtain annual recertification. Initial and ongoing comparisons of within-and between-reader variability data permitted continual assessment of group performance. Additional training and practice were provided when warranted based on evaluation of individual reading performance data.
Reproducibility Measurements
The data were obtained during a 12-month period from B-mode image recordings on 858 subjects who underwent paired ultrasound examinations 1 month apart using the uniform scanning protocols. Of the 858 patients, 405 were examined by the same sonographer and 453 by different sonographers. In neither case did sonographers have access to the IMT data from the previous examination. This process permitted both within-sonographer and between-sonographer measurement reproducibility to be individually assessed.
The clinical centers sent all ultrasound recordings to the ultrasound center where the same reader read each pair of scans. The ACAPS readers reviewed and read videotape sequences for each selected arterial segment using a standardized reading protocol. The B-mode image reading station consisted of the following instrumentation: high-resolution S-VHS videocassette recorder and 19-inch monitor, personal computer, and hardware and software for decoding arterial segment information (right/left side, near/far wall, arterial segment) that is placed on the audio channels of the videocassette by the study flow panel at the clinical center.
During the reading protocol, the ACAPS reader carefully reviewed the image sequences obtained on each segment at slow speed or frame by frame to search for those images 1) that most clearly outlined the important near wall and far wall boundaries and 2) that demonstrated the maximum IMT of the segment. Using the computer, the reader then captured and stored in digital format up to three frames per segment upon which measurements were performed. The visualized bloodintima and media-adventitia boundaries were marked with a computer-controlled cross hair at 0.5-mm intervals along the defined segment. Three examples of these measurements on B-mode images are shown in Figure 2 . From these boundary coordinates, the maximum IMT of each segment was determined by the computer and the atherosclerosis end points were calculated. The precision with which an individual cross hair can be placed on a boundary, 0.05 mm, is denned by the pixel dimension of the digitized image. The axial resolution of the ultrasound system is approximately 0.10 mm as measured using images from a standard tissue-equivalent ultrasound phantom. After transmission of data on all participants to the data coordinating center, statistical analyses were performed on the eligible population.
Using the atherosclerosis end points computed from each of the two exams (exam 1 and exam 2) for each subject, we used standard analysis methods to determine the mean, median, standard deviation, and range for the distribution of the following quantities within a specific population subset: the end point at exam 2; the arithmetic difference in the end point (exam 2-exam 1); and the absolute difference in the end point (exam 2-exam 1). When an exam yielded data on <12 segments, end point calculation was based on only those segments adequately visualized. In some individuals, end points from paired exams were obtained from the maximum IMT of different segments and/or different numbers of segments. Standard Pearson correlation coefficients were also computed for the end points obtained from the two exams. Table 1 summarizes within-sonographer and between-sonographer reproducibility data on the primary atherosclerosis end point obtained from pairs of exams performed 1 month apart and read by the same reader. Pairs of studies performed by 10 different sonographers are included in the data set, with each clinical center employing at least two sonographers. The mean value of the primary end point at exam 2 is 1.31 mm (W) and 1.32 mm (B), with the standard deviation of the arithmetic difference between exams equal to 0.13 mm (W) and 0.15 mm (B) and the mean absolute difference between exams equal to 0.10 mm (W) and 0.11 mm (B). In 90% of the exam pairs, the absolute difference is Table 3 summarizes combined within-sonographer and between-sonographer reproducibility data by clinical center. The mean primary end point at exam 2, the standard deviation of the arithmetic difference between exams, the mean absolute difference between exams, and the Pearson correlation coefficient are compared. The standard deviation of the difference ranges from 0.12 mm to 0.15 mm. The mean absolute difference ranges from 0.10 mm to 0.11 mm, and the Pearson correlation coefficient ranges from 0.72 to 0.80.
Results
In some individuals, the reader could not obtain maximum thickness data from all 12 standard arterial segments because the recorded sequence did not adequately demonstrate the wall boundaries necessary for measurement. Of the maximum attainable six maximum thickness measurements per side, the number (mean±SD) for the 858 patients during exam 2 was 5.5±0.7 (left) and 5.4+0.7 (right). The difference between exams was -0.1±0.8 (left) and -0.1±0.7 (right), showing a slight trend for fewer segments to be visualized on the second exam.
Overall, we obtained high-quality maximum thickness data on 92% of the arterial segments examined. By anatomic site, the common carotid provided the most consistent data (99%), followed by the bifurcation (96%) and the internal carotid (81%). By near or far wall, the far wall provided the higher yield (97%) compared with the near wall (87%).
The site-specific Pearson correlation coefficients between the maximum thickness measures from repeat exams varied moderately among the 12 sites, ranging from 0.50 to 0.71. No specific patterns related to anatomic location or near/far wall thickness measurements emerged in the results except for a slightly higher correlation in the bifurcation ranging from 0.63 to 0.71. Table 4 summarizes within-reader and betweenreader reproducibility data on the primary atherosclerosis end point obtained from a randomly selected subset (10%) of exam 2 patients. These were reread by either the same or a different reader. Pairs of studies performed by five different readers are included in the data set. The mean value of the primary end point at reading 2 is 1.32 mm (W) and 1.32 mm (B), with the standard deviation of the arithmetic difference between readings (reading 2-reading 1) equal to 0.07 mm (W) and 0.15 mm (B) and the mean absolute difference between readings equal to 0.06 mm (W) and 0.12 mm (B). The Pearson correlation coefficients (reading 2 versus reading 1) are 0.95 (W) and 0.73 (B). 
Discussion
The results summarized in Tables 1-5 indicate that uniform training of personnel involved in a multicenter clinical trial using standardized scanning and reading protocols achieves highly reliable end point measures of carotid atherosclerosis.
Ten sonographers at four clinical centers and five readers at the ultrasound center provided the results for this data set. The same reader, without prior knowledge of the maximum IMT measurements obtained in either examination, read each exam 1/exam 2 pair. The atherosclerosis end points are not highly dependent on the sonographer performing the scan, as evidenced by the similar within-sonographer and between-sonographer measures of reproducibility. For example, for the primary end point, the standard deviation of the arithmetic three and four times larger than those for the primary end point. This increased variability primarily results from the fact that the primary end point is the mean of 12 separate measurements compared with only a single measurement for the secondary end point. For both end points, the within-reader reproducibility is somewhat better than the between-reader results, in most cases being better than within-and between-sonographer reproducibility. The reproducibility data are highly consistent between different clinical centers.
Within-sonographer performance appears to be slightly better than between-sonographer performance when considering the 90th and 95th percentiles for the mean absolute difference between exams. For the 90% level, the results are 0.22 (W) and 0.24 (B) and for the 95% level, the results are 0.27 (W) and 0.31 (B). These largest differences are due to the incomplete circumferential scanning of one or more of the near or far wall segments in a subject. This precludes visualization and recording of the true maximum thickness within a segment. In this situation, the maximum thickness visualized on the tapes was measured and was used to compute the end points. Over time, remedial training of sonographers has reduced the number of differences >0.30 mm.
In previous work, Crouse et al 5 have reported the repeatability of a scoring system for measuring the extent of carotid atherosclerosis. They obtained the scores retrospectively from a chart review of routine clinical scans by adding the maximal lesion (wall) thickness (in millimeters) observed in 16 sites located within the extracranial carotid system. In pairs of exams performed within a period of 6 months, the Pearson correlation coefficient was 0.86, with a summary score of 0-24. Because within-sonographer reproducibility data as reported in Table 1 were not available in the study of Crouse et al, a more detailed comparison of the two methods is difficult. Additionally, significant systematic differences exist between the scanning/reading protocols used to obtain the summary score in the study of Crouse et al and the methods used to acquire the atherosclerosis end points in ACAPS. These include the definition of boundaries defining the arterial wall and lesion.
The multicenter B-scan Assessment Study used significantly different end points (IMT was not specifically measured), training methods, and scanning/reading protocols for measuring carotid atherosclerosis to obtain within-reader and between-reader repeatability data. 6 Within-and between-sonographer repeatability data were not obtained. The Pearson correlation coefficients for paired repeat readings of lesion width (thickness of lumen encroaching lesion) were 0.81 (W) and 0.56 (B).
In a single-center, population-based study of carotid atherosclerosis that used IMT measurements obtained only from the common carotid artery, Salonen and Salonen 4 reported a correlation of 0.91 between repeat scans performed 1 week apart by the same sonographer and read by different readers. The standard deviation of the difference between the two results, which were themselves the mean of three individual thickness measurements, was 0.09 mm.
The ongoing Atherosclerosis Risk in Communities (ARIC) study provided within-sonographer reproduc- ibility data acquired on repeat scans of only one arterial segment, performed during a single examination by the same sonographer after an interval of several minutes. 1112 Correlation coefficients between far wall IMT ranged from 0.67 to 0.92, depending on the specific segment being scanned. The standard deviation of the difference of single site maximum IMT measurements ranged from 0.13 mm in the common carotid to 0.39 mm in the bifurcation.
Cohort data from ARIC on within-and betweenreader reproducibility for readings of complete examinations have also been reported. 13 For maximum far wall IMT, the correlation coefficients ranged from 0.78 to 0.92 and the standard deviation of the difference was nearly the same for all arterial segments, being equal to approximately 0.15 mm.
Other studies currently using IMT measurements to study carotid artery atherosclerosis progression and regression include Pravastatin Lipids and Atherosclerosis in the Carotids (PLAC-2), the Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS), and the Carotid Artery Italian Ultrasound Study (CAIUS). 1415 The ACAPS results reported in this 16 -17 and thus to maintain a constant lumen size, does not limit the method in studying early atherosclerosis, as is the case with other techniques that are based on the measurement of arterial lumen dimensions.
With group sample sizes approaching 200 patients, small primary end point differences between treatment groups (on the order of 0.03 mm or 2% of the initial primary end point) are detectable with a high degree of confidence. This should permit clinical trials focusing on primary prevention of atherosclerosis progression to be of relatively shorter duration and to have considerably smaller sample sizes, in contrast to secondary prevention clinical trials that utilize standard morbidity and mortality end points. In principle, other arterial beds accessible to ultrasonic examination could be studied in a similar manner with this highly reliable, noninvasive methodology. 
